Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells.

British Journal of Pharmacology
Yun NingJ A Hedrick

Abstract

GPR119 is a G protein-coupled receptor that is preferentially expressed in islet cells and mediates insulin secretion. Oleoyl-lysophosphatidylcholine and oleoylethanolamide (OEA) act as endogenous ligands for this receptor, whereas PSN375963 and PSN632408 are two recently reported synthetic agonists. In this study, we explored mechanisms underlying GPR119-induced insulin secretion. In addition, we assessed the potential utility of the synthetic agonists as tools for exploring GPR119 biology. We examined natural and synthetic GPR119 agonist activity at GPR119 in MIN6c4 and RINm5f insulinoma cells. We evaluated insulin secretion, intracellular calcium [Ca(2+)](i), ion channel involvement and levels of cAMP. We report that increases in insulin secretion induced by OEA were associated with increased cAMP and a potentiation of glucose-stimulated increases in [Ca(2+)](i). We also demonstrate that ATP-sensitive K(+) and voltage-dependent calcium channels were required for GPR119-mediated increases in glucose-stimulated insulin secretion. In contrast to OEA, the synthetic GPR119 agonist PSN375963 and PSN632408 have divergent effects on insulin secretion, cAMP and intracellular calcium in MIN6c4 cells. The endogenous ligand OEA signals ...Continue Reading

References

Dec 1, 1992·Pflügers Archiv : European journal of physiology·T Ohno-Shosaku, C Yamamoto
Feb 4, 1999·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·N H McClenaghan, P R Flatt
Oct 26, 1999·Endocrine Reviews·B Desvergne, W Wahli
Nov 1, 2002·The Journal of Biological Chemistry·Yazhou LiDaniel J Drucker
Apr 3, 2004·Journal of Lipid Research·Mie Julin NielsenHarald S Hansen
Dec 21, 2004·Biochemical and Biophysical Research Communications·Takatoshi SogaKiyoshi Furuichi
May 10, 2005·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Karine ProulxRandy J Seeley
Mar 7, 2006·Cell Metabolism·Daniel J Drucker
May 17, 2006·The Journal of Pharmacology and Experimental Therapeutics·Giuseppe AstaritaDaniele Piomelli

❮ Previous
Next ❯

Citations

Oct 13, 2009·Diabetes, Obesity & Metabolism·M A KebedeV Poitout
Aug 1, 2010·Therapeutic Advances in Endocrinology and Metabolism·Venkat VangavetiR Lee Kennedy
Jan 24, 2014·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S PatelH M Cox
Jan 24, 2013·American Journal of Physiology. Endocrinology and Metabolism·Yan LiRobert F Margolskee
Feb 28, 2013·Expert Opinion on Investigational Drugs·Lauren M CornallAndrew J McAinch
Feb 2, 2012·Expert Opinion on Investigational Drugs·Takahide Ohishi, Shigeru Yoshida
Aug 19, 2015·Proceedings of the National Academy of Sciences of the United States of America·Louis J CohenSean F Brady
Mar 17, 2009·Best Practice & Research. Clinical Endocrinology & Metabolism·Luciano De Petrocellis, Vincenzo Di Marzo
Jul 19, 2018·Assay and Drug Development Technologies·Ainhoa NietoPatricia H McDonald
Jul 20, 2017·Diabetes, Obesity & Metabolism·Jin Won YangKeon Wook Kang
Nov 13, 2015·PloS One·Nagendra YaluriMarkku Laakso
Nov 11, 2009·Molecular Endocrinology·Zhi-Liang ChuJames Leonard
Sep 29, 2009·Expert Opinion on Therapeutic Patents·Robert M JonesJuerg Lehmann
Oct 28, 2011·British Journal of Pharmacology·Virginia M StoneNoel G Morgan
May 28, 2019·International Journal of Molecular Sciences·Ivonne Bazwinsky-WutschkeFaramarz Dehghani
Feb 13, 2014·British Journal of Pharmacology·Stephen P H AlexanderUNKNOWN CGTP Collaborators
Jun 28, 2014·Science China. Life Sciences·Jue Wang, RuiPing Xiao
Mar 13, 2012·Pharmacological Reviews·E J Verspohl
Jan 12, 2012·Current Opinion in Clinical Nutrition and Metabolic Care·Marco A R VinoloRui Curi
Jan 8, 2011·Phytotherapy Research : PTR·Jonathan A FarrimondClaire M Williams
Sep 6, 2013·Médecine sciences : M/S·Arturo D Mancini, Vincent Poitout
Oct 27, 2017·Frontiers in Pharmacology·Ken SoderstromRukiyah Van Dross
Oct 5, 2018·Frontiers in Endocrinology·Ivan N TyurenkovRuben N Karapetian
Jan 27, 2021·International Journal of Molecular Sciences·Dong-Soon Im
Nov 19, 2020·American Journal of Physiology. Gastrointestinal and Liver Physiology·Ryan KurtzBlythe D Shepard
May 29, 2021·Bioorganic Chemistry·Ajay ManaithiyaImran A Khan
Jul 9, 2021·Cellular & Molecular Biology Letters·Jianan ZhaoJinghua Peng
Jul 21, 2009·Prostaglandins & Other Lipid Mediators·Grzegorz GodlewskiGeorge Kunos
Aug 8, 2009·Biochemical Pharmacology·Noel G Morgan, Shalinee Dhayal
Jun 15, 2010·The International Journal of Biochemistry & Cell Biology·Aurore André, Marie-Paule Gonthier

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

GraphPad
GraphPad Prism
Sequence Detection Systems

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.